SCHEMBL8499285

SCHEMBL8499285

O=C1CCN1C1CO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8831896 0.86 — —
SCHEMBL6838598 0.72 PIK3C3 (0.31) —
SCHEMBL4740264 0.69 TP53 (0.33) —
SCHEMBL6843578 0.66 ALDH1A1 (0.38) —
SCHEMBL6845722 0.65 ALDH1A1 (0.37) —
SCHEMBL17599181 0.64 CDA (0.45) —
SCHEMBL11515949 0.63 POLB (0.44) —
SCHEMBL4605352 0.63 POLB (0.44) —
SCHEMBL4974460 0.62 MAPK1 (0.33) —
SCHEMBL15014099 0.61 TP53 (0.42) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0751934-B1 SUBSTITUTED AZETIDINONE COMPOUNDS USEFUL AS HYPOCHOLESTEROLEMIC AGENTS SCHERING CORP (US) 1999-08-25 — — EP disclosed
US-5688990-A FORMING CHEMICAL INTERMEDIATES FOR AZETIDINONE COMPOUNDS THAT INHIBIT CHOLESTEROL BIOSYNTHESIS FOR PREVENTION OF ATHEROSCLEROSIS SHANKAR BANDARPALLE B (US) 1997-11-18 — — US disclosed
US-5627176-A MIXED WITH CHOLESTEROL BIOSYNTHESIS INHIBITOR; PREVENTING ATHEROSCLEROSIS SCHERING CORPORATION (US) 1997-05-06 — — US disclosed
EP-0751934-A1 SUBSTITUTED AZETIDINONE COMPOUNDS USEFUL AS HYPOCHOLESTEROLEMIC AGENTS SCHERING CORPORATION (US) 1997-01-08 — — EP disclosed
WO-1995026334-A1 SUBSTITUTED AZETIDINONE COMPOUNDS USEFUL AS HYPOCHOLESTEROLEMIC AGENTS SCHERING CORPORATION (US) 1995-10-05 — — WO disclosed
Send feedback